The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

PET-MR for Cardiac Sarcoidosis

Hybrid 18F-FDG PET combined with cardiac MRI for one-stop diagnosis and disease activity assessment in cardiac sarcoidosis with both inflammation and fibrosis quantification.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Radyoloji department. Book Appointment →

What is PET-MR for Cardiac Sarcoidosis?

PET-MR for cardiac sarcoidosis is a hybrid imaging modality that simultaneously acquires 18F-fluorodeoxyglucose positron emission tomography (revealing active inflammatory cellular metabolism) and high-resolution cardiac magnetic resonance imaging (showing structural and tissue characterization including late gadolinium enhancement, edema, and ventricular function).

Diagnostic principle — active sarcoid granulomas demonstrate increased FDG uptake reflecting inflammatory cell metabolism, while LGE on cardiac MRI represents fibrotic scar from prior or ongoing inflammation; concordant patterns confirm cardiac sarcoidosis with high specificity.

Clinical applications include initial diagnosis when endomyocardial biopsy is technically challenging or low yield, monitoring response to corticosteroid or methotrexate therapy with quantitative SUV reduction indicating treatment success, and identification of patients requiring intensified immunosuppression or device therapy.

Symptoms

Suspected cardiac sarcoidosis with conduction abnormalities
Unexplained cardiomyopathy in young or middle-aged adult
Confirmed extracardiac sarcoidosis with cardiac symptoms
Ventricular tachyarrhythmias with structurally abnormal heart
Pre-treatment baseline assessment before immunosuppression
Treatment response monitoring during immunosuppressive therapy
Negative endomyocardial biopsy with strong clinical suspicion

Risk Factors

Renal failure precluding gadolinium contrast
Implanted MRI-incompatible cardiac devices
Severe claustrophobia preventing MRI completion
Active diabetes mellitus with poor glucose control
Recent steroid administration affecting FDG uptake
Limited availability of hybrid PET-MR scanners
Pregnancy and lactation

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Suspected cardiac sarcoidosis with characteristic clinical presentation
  • Confirmed pulmonary or systemic sarcoidosis with cardiac symptoms
  • Unexplained heart block in young adult
  • Need for active inflammation versus fibrosis differentiation
  • Treatment monitoring during immunosuppression
  • Pre-ICD implantation risk stratification
  • Tertiary referral cardiac sarcoidosis center evaluation

Treatment Methods

01
Strict 12-24 hour high-fat low-carbohydrate diet to suppress myocardial glucose uptake
02
Heparin injection 50 IU/kg 15 minutes before FDG to enhance suppression
03
Simultaneous PET and cardiac MRI acquisition with gadolinium
04
Quantitative SUV measurement and volumetric LGE quantification
05
Multidisciplinary review with cardiologist, pulmonologist, nuclear medicine
06
Treatment response monitoring with serial scans every 3-6 months
07
Reporting using consensus criteria (HRS, JCS guidelines)

Which Department to Visit?

You can visit our Radyoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Radyoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.